Jeff Myers
Chief Tech/Sci/R&D Officer bei BEYOND AIR, INC.
Vermögen: 81 044 $ am 31.03.2024
Profil
Jeff Myers is currently the Director at Bioceptive, Inc. and the Chief Medical Officer at Beyond Air, Inc. He previously worked as the Vice President-Medical Affairs at Portola Pharmaceuticals LLC in 2020, the Chief-Pediatric Cardiac Surgery at The General Hospital Corp.
from 2007 to 2009, the Chief-Pediatric Cardiac Surgery at Tulane Medical Center from 2003 to 2005, the Vice President-Medical Affairs at SteadyMed Ltd.
from 2017 to 2019, and the Chief Medical Officer at Revolo Biotherapeutics Ltd.
from 2020 to 2022.
Dr. Myers holds a doctorate degree from the University of Oklahoma College of Medicine and Georgetown University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BEYOND AIR, INC.
0,13% | 27.12.2023 | 46 577 ( 0,13% ) | 81 044 $ | 31.03.2024 |
Aktive Positionen von Jeff Myers
| Unternehmen | Position | Beginn |
|---|---|---|
| BEYOND AIR, INC. | Chief Tech/Sci/R&D Officer | 27.03.2023 |
Bioceptive, Inc.
 Bioceptive, Inc. Medical SpecialtiesHealth Technology Bioceptive, Inc. develops medical devices for gynecological procedures. Its products includes, intrauterine device (IUD) inserter that vastly simplifies the insertion procedure, while reducing the complications inherent with current insertion techniques. The company was founded by Shuchi Khurana and Benjamin D. Cappiello in September 2010 and is ehadquartered in New Orleans, LA. | Director/Board Member | - |
Ehemalige bekannte Positionen von Jeff Myers
| Unternehmen | Position | Ende |
|---|---|---|
Revolo Biotherapeutics Ltd.
 Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Chief Tech/Sci/R&D Officer | 01.02.2022 |
| PORTOLA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01.10.2020 |
| STEADYMED LTD | Chief Tech/Sci/R&D Officer | 01.01.2019 |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01.01.2009 |
Tulane Medical Center
 Tulane Medical Center Hospital/Nursing ManagementHealth Services Tulane Medical Center operates hospitals. The private company is based in New Orleans, LA. The company was founded in 1834. William Lunn has been the CEO of the company since 2014. | Corporate Officer/Principal | 01.01.2005 |
Ausbildung von Jeff Myers
| University of Oklahoma College of Medicine | Doctorate Degree |
| Georgetown University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BEYOND AIR, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Bioceptive, Inc.
Bioceptive, Inc. Medical SpecialtiesHealth Technology Bioceptive, Inc. develops medical devices for gynecological procedures. Its products includes, intrauterine device (IUD) inserter that vastly simplifies the insertion procedure, while reducing the complications inherent with current insertion techniques. The company was founded by Shuchi Khurana and Benjamin D. Cappiello in September 2010 and is ehadquartered in New Orleans, LA. | Health Technology |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
Tulane Medical Center
Tulane Medical Center Hospital/Nursing ManagementHealth Services Tulane Medical Center operates hospitals. The private company is based in New Orleans, LA. The company was founded in 1834. William Lunn has been the CEO of the company since 2014. | Health Services |
SteadyMed Ltd.
 SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology SteadyMed Ltd. was engaged in the research, development, and manufacture of pharmaceutical products through the PatchPump technology. Its portfolio included Trevyent for pulmonary arterial hypertension and At Home Patient Analgesia for post-surgical pains. The company was founded on June 15, 2005 and was headquartered in Rehovot, Israel. | Health Technology |
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Revolo Biotherapeutics Ltd. develops immunologic and inflammatory medications. It develops disease resetting therapeutics for immuno-inflammatory diseases. The company was founded in 2011 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
